Association of Vitiligo With Immune-Checkpoint Inhibitor Therapy: A Systematic Review
Author Type(s)
Student
Document Type
Article
Publication Date
2-1-2025
DOI
10.1016/j.jdin.2024.10.005
Journal Title
Jaad International
Keywords
immune-related adverse events, immunotherapy, immunotoxicity, nivolumab, pembrolizumab, vitiligo
Disciplines
Medicine and Health Sciences
Recommended Citation
Fleshner, L., Roster, K., Xie, L., & Lipner, S. (2025). Association of Vitiligo With Immune-Checkpoint Inhibitor Therapy: A Systematic Review. Jaad International, 18, 119-121. https://doi.org/10.1016/j.jdin.2024.10.005
COinS
